×
-0.00689655172413778 -0.00689655172413778 -0.00689655172413778 -0.00689655172413778 -0.0160919540229884 -0.0206896551724138 -0.0214252873563217 -0.0214252873563217
Stock impact report

Guillain-Barre Syndrome - Pipeline Insight, 2018 - ResearchAndMarkets.com

Akari Therapeutics Plc ADS (AKTX)  More Company Research Source: Business Wire
US:NASDAQ Investor Relations: investor.akaritx.com/investor-relations
PDF DUBLIN--(BUSINESS WIRE)-- The "Guillain-Barre Syndrome - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. This report offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Guillain-Barre Syndrome development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Scope The report provides a snapshot of the pipeline development for Guillain-Barre Syndrome The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Guillain-Barre Syndrome The report [Read more]
Impact snapshot Event time: AKTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
AKTX alerts

from News Quantified
Opt-in for
AKTX alerts

from News Quantified